Treatment of Hereditary Hemochromatosis in Pregnancy or Planned Pregnancy

Hereditary hemochromatosis requires careful management when pregnancy is planned or ongoing. The presence of pregnancy — or active planning for it — changes how iron overload is approached, particularly when the degree of overload is mild to moderate and there is no advanced liver disease.

Clinical scenario Haemochromatosis with pregnancy or planned pregnancy; mild to moderate iron overload without advanced liver disease. Iron deficiency must be actively avoided in this population, making the usual treatment targets different from the standard approach.

Treatment goal Serum ferritin maintained at ≥45 µg/L — a conservative threshold that avoids iron deficiency while managing iron overload during and around pregnancy.

Approach (partial) Management centres on therapeutic phlebotomy, but the intensity is specifically adjusted to protect against iron deficiency in this setting. The full decision algorithm — including when and how to modify or pause treatment around pregnancy — is detailed in the structured protocol. Full regimen, sequencing, and individualisation criteria available in the protocol →

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1016/j.jhep.2022.03.033

In patients with haemochromatosis planning to get pregnant, iron deficiency should be avoided.

In patients with haemochromatosis planning to get pregnant, the intensity of therapeutic phlebotomy should be reduced to achieve serum ferritin concentrations of ≥45 µg/L, which is a conservative cut-off for iron deficiency suggested by recent guidelines.

In pregnant women with mild to moderate iron overload without signs of advanced liver disease, decisions regarding therapeutic phlebotomy can be individualised but phlebotomy can be paused for the duration of pregnancy in most patients.

View source ↗